iCanQuit App + Nicotine Therapy for Smoking Cessation
Trial Summary
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using other smoking cessation interventions or if you are using warfarin.
What data supports the effectiveness of the iCanQuit App + Nicotine Therapy treatment for smoking cessation?
Research shows that nicotine replacement therapies like patches, gum, and lozenges help many people quit smoking. Combining different nicotine therapies, such as a patch with another form, may be even more effective. This suggests that using the iCanQuit App along with nicotine products could help people stop smoking.12345
Is the iCanQuit App + Nicotine Therapy safe for humans?
Nicotine replacement therapies like gum, lozenges, and patches are generally safe for most people, including those with heart conditions, but should be used cautiously during pregnancy. These therapies are well-tolerated, with minor side effects reported, and are effective in helping people quit smoking.56789
How does the iCanQuit App + Nicotine Therapy treatment differ from other smoking cessation treatments?
The iCanQuit App + Nicotine Therapy is unique because it combines digital support through an app with traditional nicotine replacement therapies like gum, lozenges, and patches, potentially enhancing motivation and support for quitting smoking. This approach integrates behavioral support with pharmacological intervention, which may improve quit rates compared to using nicotine replacement alone.1571011
What is the purpose of this trial?
This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.
Research Team
Jonathan Bricker, PhD
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Eligibility Criteria
This trial is for Hispanic adults who want to quit smoking and are willing to use a smartphone app designed to help with quitting. Participants must be comfortable using the iCanQuit app, which includes managing urges and creating personalized quit plans. There's no mention of specific exclusions in the provided information.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to the iCanQuit smartphone application for 12 months, with personalized quit plans and education on managing urges, motivation, and relapse prevention. Arm II participants also receive NRT patches and gum or lozenges.
Follow-up
Participants are monitored for smoking cessation outcomes and cost-effectiveness measures at 12 months post-randomization.
Treatment Details
Interventions
- iCanQuit Smartphone App Smoking Cessation Program
- Nicotine Gum
- Nicotine Lozenge
- Nicotine Patch
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator